697 related articles for article (PubMed ID: 12164088)
1. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
2. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
3. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
4. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
[TBL] [Abstract][Full Text] [Related]
5. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
6. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
7. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
8. Low calcium dialysate and hyperparathyroidism.
Duncan R; Cochrane T; Bhalla C; Michael J; Richards NT; Adu D
Perit Dial Int; 1996; 16 Suppl 1():S499-502. PubMed ID: 8728256
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients.
Navarro JF; Mora C; Jiménez A; Torres A; Macía M; García J
Am J Kidney Dis; 1999 Jul; 34(1):43-8. PubMed ID: 10401014
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic changes in calcium and phosphate plasma concentrations in the patients on peritoneal dialysis].
Jovanović N; Lausević M; Stojimirović B
Vojnosanit Pregl; 2006 Jan; 63(1):27-30. PubMed ID: 16471245
[TBL] [Abstract][Full Text] [Related]
11. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.
Pasadakis P; Thodis E; Mourvati E; Euthimiadou A; Margaritis D; Manavis J; Vargemezis V
Adv Perit Dial; 1996; 12():245-9. PubMed ID: 8865913
[TBL] [Abstract][Full Text] [Related]
13. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
Takahashi S; Okada K; Yanai M
Perit Dial Int; 1994; 14(1):75-8. PubMed ID: 8312420
[TBL] [Abstract][Full Text] [Related]
14. Differences in calcium kinetic pattern between CAPD and HD patients.
Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
[TBL] [Abstract][Full Text] [Related]
15. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J
Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024
[TBL] [Abstract][Full Text] [Related]
16. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
[TBL] [Abstract][Full Text] [Related]
17. The influence of dialysate calcium concentration on the PTH level in children undergoing CAPD.
Sieniawska M; Roszkowska-Blaim M; Wojciechowska B
Perit Dial Int; 1996; 16 Suppl 1():S567-9. PubMed ID: 8728272
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
[TBL] [Abstract][Full Text] [Related]
19. Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
Rotellar C; Kinsel V; Goggins M; Tarman G; Stull M; Mazzoni MJ; Mosher WF; Rakowski TA; Winchester JF
Perit Dial Int; 1993; 13 Suppl 2():S471-2. PubMed ID: 8399643
[TBL] [Abstract][Full Text] [Related]
20. Secondary hyperparathyroidism in diabetic and nondiabetic patients on long-term continuous ambulatory peritoneal dialysis (CAPD).
Nilsson P; Danielson BG; Grefberg N; Wide L
Scand J Urol Nephrol; 1985; 19(1):59-65. PubMed ID: 4023650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
